Physician profile
Taylor Rose
NPI 1972067908
$1,043.44
in general payments reported to CMS, 2019-2025
15 companies · $681 in 2025
The $681 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.01 · 2022: $20.35 · 2023: $225 · 2024: $103 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $225.76 | 2025 | |
| Immunitybio, INC. | $147.00 | 2025 | |
| Sumitomo Pharma America, INC. | $126.54 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $114.98 | 2023 | Padcev |
| E.R. Squibb & Sons, L.L.C. | $113.58 | 2025 | Opdivo |
| Boston Scientific Corporation | $60.09 | 2025 | Spaceoar System |
| Janssen Scientific Affairs, LLC | $51.67 | 2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $48.06 | 2022-2024 | Mychoice Cdx |
| Axonics, INC. | $28.60 | 2024 | Axonics |
| Medtronic, INC. | $25.27 | 2024 | Interstim |
| Janssen Biotech, INC. | $23.62 | 2025 | Erleada |
| Teleflex LLC | $23.57 | 2025 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $21.02 | 2024 | |
| Caris Mpi, INC. | $18.67 | 2025 | Mi Cancer Seek |
| Nuvasive, INC. | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.